TRPS1

Chr 8AD

transcriptional repressor GATA binding 1

Also known as: GC79, LGCR

This gene encodes a transcription factor that represses GATA-regulated genes and binds to a dynein light chain protein. Binding of the encoded protein to the dynein light chain protein affects binding to GATA consensus sequences and suppresses its transcriptional activity. Defects in this gene are a cause of tricho-rhino-phalangeal syndrome (TRPS) types I-III. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.113 OMIM phenotypes
Clinical SummaryTRPS1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
184 unique Pathogenic / Likely Pathogenic· 365 VUS of 851 total submissions
📖
GeneReview available — TRPS1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.11LOEUF
pLI 1.000
Z-score 5.92
OE 0.02 (0.010.11)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
1.54Z-score
OE missense 0.83 (0.780.89)
562 obs / 674.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.02 (0.010.11)
00.351.4
Missense OE?0.83 (0.780.89)
00.61.4
Synonymous OE?1.05
01.21.6
LoF obs/exp: 1 / 42.9Missense obs/exp: 562 / 674.8Syn Z: -0.60
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveTRPS1-related trichorhinopharangeal syndromeLOFAD

This gene — mechanism propensity

DN
0.2299th %ile
GOF
0.2098th %ile
LOF
0.87top 5%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 1 literature citation · 84% of P/LP variants are LoF · LOEUF 0.11 · ClinGen HI: Sufficient evidence for dosage pathogenicity
DN1 literature citation

Literature Evidence

DNThe patient with type I TRPS had haploinsufficiency of TRPS1, whereas the patient with type III TRPS had an allele causing functional modification of the GATA-type motif, possibly inducing a dominant-negative effect on DNA transcription regulation and leading to a more severe phenotype.1
LOFLanger-Giedion's syndrome (LGS) or trichorhinophalangeal syndrome type II (TRPS II; MIM:150230) is a contiguous gene deletion syndrome caused by the haploinsufficiency of the TRPS1 and EXT1 genes.2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

851 submitted variants in ClinVar

Classification Summary

Pathogenic136
Likely Pathogenic48
VUS365
Likely Benign189
Benign50
Conflicting32
136
Pathogenic
48
Likely Pathogenic
365
VUS
189
Likely Benign
50
Benign
32
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
123
6
7
0
136
Likely Pathogenic
32
15
1
0
48
VUS
5
352
6
2
365
Likely Benign
0
45
16
128
189
Benign
0
8
24
18
50
Conflicting
32
Total16042654148820

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

63 pathogenic / likely-pathogenic (of 67) ClinVar copy-number / structural variants overlap TRPS1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TRPS1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →